Aspalathus linearis (Rooibos) Targets Adipocytes and Obesity-Associated Inflammation

Excess weight and obesity are the fifth leading cause of death globally, and sustained efforts from health professionals and researchers are required to mitigate this pandemic-scale problem. Polyphenols and flavonoids found in Aspalathus linearis—a plant widely consumed as Rooibos tea—are increasingly being investigated for their positive effects on various health issues including inflammation. The aim of our study was to examine the effect of Rooibos extract on obesity and the associated low-grade chronic inflammatory state by testing antioxidant activity, cytokine secretions, macrophage polarization and the differentiation of human adipocytes through the development of adipospheroids. Rooibos extract significantly decreased ROS production and the secretion of pro-inflammatory cytokines (IFN-γ, IL-12, IL-2 and IL-17a) in human leukocytes. Additionally, Rooibos extract down-regulated LPS-induced macrophage M1 polarization, shown by a significant decrease in the expression of pro-inflammatory cytokines: TNFα, IL-8, IL-6, IL-1β and CXCL10. In addition, Rooibos inhibited intracellular lipid accumulation and reduced adipogenesis by decreasing the expression of PPARγ, Ap2 and HSL in adipospheroids. A significant decrease in leptin expression was noted and this, more interestingly, was accompanied by a significant increase in adiponectin expression. Using a co-culture system between macrophages and adipocytes, Rooibos extract significantly decreased the expression of all studied pro-inflammatory cytokines and particularly leptin, and increased adiponectin expression. Thus, adding Rooibos tea to the daily diet is likely to prevent the development of obesity associated with chronic low-level inflammation.

[1]  Caroline Vachias,et al.  A bicellular fluorescent ductal carcinoma in situ (DCIS)-like tumoroid to study the progression of carcinoma: practical approaches and optimization. , 2023, Biomaterials science.

[2]  A. Kappo,et al.  In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response , 2022, Toxicology reports.

[3]  H. Assi,et al.  Metabolic Syndrome: Updates on Pathophysiology and Management in 2021 , 2022, International journal of molecular sciences.

[4]  C. Muller,et al.  New Insights into the Efficacy of Aspalathin and Other Related Phytochemicals in Type 2 Diabetes—A Review , 2021, International journal of molecular sciences.

[5]  G. Guyatt,et al.  Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials , 2021, The Lancet.

[6]  D. Ryan Drugs for Treating Obesity. , 2021, Handbook of experimental pharmacology.

[7]  Naeem Sheik Abdul,et al.  Rooibos, a supportive role to play during the COVID-19 pandemic? , 2021, Journal of Functional Foods.

[8]  Wadii Boulila,et al.  A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity , 2021, Comput. Biol. Medicine.

[9]  C. Calkhoven,et al.  Obesity and its impact on COVID-19 , 2021, Journal of Molecular Medicine.

[10]  E. Kalkhoven,et al.  PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action , 2021, Frontiers in Endocrinology.

[11]  T. Pers,et al.  Hypothalamic hormone-sensitive lipase regulates appetite and energy homeostasis , 2021, Molecular Metabolism.

[12]  S. Y. Lee,et al.  Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? , 2021, Current Obesity Reports.

[13]  D. Langin,et al.  Hormone-sensitive lipase: sixty years later. , 2020, Progress in lipid research.

[14]  Tatsuo Kawai,et al.  Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. , 2020, American journal of physiology. Cell physiology.

[15]  J. Eilers,et al.  Multinucleated Giant Cells in Adipose Tissue Are Specialized in Adipocyte Degradation , 2020, Diabetes.

[16]  A. Capasso,et al.  Obesity: the New Global Epidemic. Pharmacological Treatment, Opportunities and Limits for Personalized Therapy. , 2020, Endocrine, metabolic & immune disorders drug targets.

[17]  K. Zorena,et al.  Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications , 2020, International journal of molecular sciences.

[18]  D. Mcclements,et al.  Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical , 2020, Critical reviews in food science and nutrition.

[19]  Michael E. Hall,et al.  Obesity, Hypertension, and Cardiac Dysfunction , 2020, Circulation research.

[20]  F. Caldefie‐Chézet,et al.  In Vitro Anti-Inflammatory and Immunomodulatory Activities of an Extract from the Roots of Bupleurum rotundifolium , 2019, Medicines.

[21]  G. Paragh,et al.  The Impact of Obesity on the Cardiovascular System , 2018, Journal of diabetes research.

[22]  G. Frühbeck,et al.  Adipokine dysregulation and adipose tissue inflammation in human obesity , 2018, European journal of clinical investigation.

[23]  R. Judd,et al.  Adiponectin Regulation and Function. , 2018, Comprehensive Physiology.

[24]  Arielle Rowe,et al.  Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery , 2018, International journal of molecular sciences.

[25]  J. Ankrum,et al.  Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery , 2018, Scientific Reports.

[26]  C. Apovian,et al.  Updates on obesity pharmacotherapy , 2018, Annals of the New York Academy of Sciences.

[27]  Neil Miller,et al.  Minimising variation in aspalathin content of aqueous green rooibos extract: optimising extraction and identifying critical material attributes. , 2017, Journal of the science of food and agriculture.

[28]  C. Apovian Obesity: definition, comorbidities, causes, and burden. , 2016, The American journal of managed care.

[29]  P. Scherer,et al.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.

[30]  T. Sen,et al.  Medicinal plants, human health and biodiversity: a broad review. , 2014, Advances in biochemical engineering/biotechnology.

[31]  P. López-Jaramillo,et al.  The role of leptin/adiponectin ratio in metabolic syndrome and diabetes , 2014, Hormone molecular biology and clinical investigation.

[32]  C. Pheiffer,et al.  Effects of fermented rooibos (Aspalathus linearis) on adipocyte differentiation. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[33]  Y. Miura,et al.  Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice , 2013, European Journal of Nutrition.

[34]  A. Hahn,et al.  Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations. , 2011, Food chemistry.

[35]  I. Iswaldi,et al.  Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[36]  J. Sprent,et al.  African legumes: a vital but under-utilized resource. , 2010, Journal of experimental botany.

[37]  G. Williamson,et al.  The C-glycosyl flavonoid, aspalathin, is absorbed, methylated and glucuronidated intact in humans. , 2009, Molecular nutrition & food research.

[38]  A. Stalmach,et al.  Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. , 2009, Journal of agricultural and food chemistry.

[39]  M. Huang,et al.  Transport of aspalathin, a Rooibos tea flavonoid, across the skin and intestinal epithelium , 2008, Phytotherapy research : PTR.

[40]  B. Conway,et al.  Obesity as a disease: no lightweight matter , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[41]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[42]  L. Igel,et al.  Obesity Pharmacotherapy. , 2018, The Medical clinics of North America.

[43]  LSU Digital Commons LSU Digital Commons Adipogenesis Adipogenesis , 2022 .